09:00 

Presidents's Introduction - Becky Upton

09:10 

Keynote Presentation: AI, Data and their impact on life science research 

Dame Janet Thornton, Former Director, EMBL-EBI 

09:35 

Pistoia Alliance Portfolio Update 

• Harnessing AI To Expedite R&D 
• Deliver Data Driven Value in R&D 
• Accelerate Use of Real-World Data and Evidence 
• Sustainability Drive R&D 
  Christian Baber, Chief Portfolio Officer, Pistoia Alliance

The IVP & GSRS Project

Larry Callahan, Lead Scientist - Substance Registration System, FDA

Focus on Ontologies 

• Clinical Operations
  Aditya Tyagi, Project Manager, Pistoia Alliance and Cameron Gibbs, Ontologist, Crownpoint Technologies 
  
  
• CMC (ISA88) Process Ontology 
  Birthe Nielsen, Project Manager, Pistoia Alliance and Cameron Gibbs, Ontologist, Crownpoint Technologies 
  
  
• Pharma General Ontology (PGO)
  Giovanni Nisato, Project Manager, Pistoia Alliance 

Morning Coffee 

HARNESSING AI TO EXPEDITE R&D

Keynote Address 
James Malone, CTO, Benevolent AI 

Democratising Date in Life Sciences Workshop Feedback
Jane Lomax, Head of Ontologies, Scibite 

RAVEN - AI Generated Molecules in Drug-like Space

Mark Griffiths, Senior Data and Knowledge Scientist, AbbVie 

AI Revolution in Healthcare: Trends Shaping the Future of Medicine

Sridevi Nagarajan, Head Digital Regulatory Strategy, AstraZeneca

Using human genetics and genomics data for systematic drug target identification and prioritisation
Ellen McDonagh, Translational Informatics Director, Open Targets 

Partners in R&D Innovation - Sponsored Talks 

• Data continuity in the connected lab - addressing data orchestration challenges in complex multi-stage experiments
  Max Petersen, Lab Data Automation Practice  Manager, Zifo 
  
  
• Ontologies & LLMss - democratising scientific data 
  Joe Mullen, Director Data Science & Professional Services, SciBite 
  
  
• Valentina Eigner-Pitto, Principal Solutions, Consultant, CAS

The R(e)volution of Digital Health 
Bruce Press, Principal, and Adam Schneider, Director of Strategy & Operations, R&D , ZS Associates 

LUNCH & NETWORKING 

IDMP - Ontology Ready Survey, key findings 

Melih Tuzunoglu, Project Manager, Pistoia Alliance 

Heiner Oberkampf, Managing Director, ACCURIDS

Shelia Elz, Master Data Manager, Bayer 

Dominik Gigli, Management Consultant, MAIN5

ACCELERATE USE OF REAL-WORLD DATA & EVIDENCE 

Usage of AI to better leverage RWD 

Kailash Swarna, Managing Director, Accenture 

Co-ordinating Efforts to address RWD Challenges

Lianna Ishihara, Senior Director Real World Data Strategy and Partnerships, GSK 

• Building an ontology to FAIRify RWD Metadata
  
  
• Metadata is essential to enable the findability of RWD data sources, their comparability and to do a preliminary assessment of fitness-for-purpose
• Some catalogues provide a comprehensive list of fields, but they don’t follow a FAIR representation, with all implied limitations.
• We propose a project to develop jointly a FAIR version of RWD Metadata (RWD ontology)

Andrea Splendiani, Principal, IQVIA 

Facilitated Q&A 

COFFEE & BREAKOUT SESSIONS 

BREAKOUT ONE 

Deliver Data Driven Value in R&D 
Moderator: Becky Upon, President, Pistoia Alliance 

Data is the foundation for emerging technologies like Generative AI, but the industry still struggles to manage, maintain, and share data effectively. This session will address these common challenges and propose solutions that that leverage ontologies, data enrichment, and data integration technologies.

15:45 FAIR and the Maturity Model Giovanni Nisato, Pistoia Alliance

16.00 Navigating the Transition: From Models to Deployed AI in Life Sciences R&D

Swetabh Pathak, Co-founder & CTO, Elucidata

16:15 From Data Strategy to Delivery: Conciliating scientists' data needs with business consultants, Felipe Albrecht, Senior Scientist, Roche

16.30 Cause-and-Effect to Empower Drug Discovery In A Generative AI World, Daniel Jamieson, CEO, Biorelate

16:45  Panel Discussion and Q&A

BREAKOUT TWO 

Accelerate Use of Real-World Data and Evidence 
Moderator: Thierry Escudier, Portfolio Lead, Pistoia Alliance 

The rise of wearables, internet of things (IOT) devices, social media and electronic health records holds huge promise for collecting and sharing patient data and enabling them to be more involved in their care. This session will examine how we can harness and utilise this data in an accurate and ethical way.

15:45  Enabling Life Sciences research with OHDSI, open source standards and tools, Gregory Klebanov, CEO,Odysseus Data Services

16:00 Unlocking the potential of real world data through federated data networks, Michel Van Speybroeck, Director Data Sciences, J&J Innovative Medicines 

16.15 Differentiating "value" in the real world to drive competitive advantage, Vaneet Nayar, Sr Director RWE: Access Consulting, Parexel

16:30 Panel Discussion and Q&A

BREAKOUT THREE 

Pistoia Alliance Communities Session 
Moderator: Christian Baber, Chief Portfolio Officer, Pistoia Alliance 

The power of collaborative R&D is evidenced across our many communities which bring together expertise from different companies and industries, solving common challenges together, and driving innovation for the good of all. Here we will review our current portfolio of communities and discuss how our members can get involved.

15.45 Panel Discussion: How communities work

16:15 CSCS: 

Nicolas Fur, Head of Controlled Substance Program, Novartis Pharma

Zofia Jordan, Consultant, ChemAxon

16.30 UXLS, Rob Graham, Global Head of User Experience, AstraZeneca 

16.45 Unlocking Hidden Blocks: Leveraging User-Centred Approaches in digital transformation,  RockStep Solutions

17.00 Upcoming communities:

• Lab of the Future
• FAIR
• Digital adoption/change management

Closing Keynote Address:

Driving AI in BioPharma through a new generation of public/private partnerships

Angeli Moller, Head of DIGI (Data and Integrations Generating Insights), Roche 

Closing Remarks & Drinks Reception